Cosciens Biopharma INC. (CSCIF) SEC Filings — 2024

Filings

• Cosciens Biopharma Files 6-K Report — 6-K · Dec 23, 2024
• Cosciens Biopharma Files Routine 6-K Report — 6-K · Nov 12, 2024
• Cosciens Biopharma Files 6-K Report — 6-K · Oct 8, 2024
• Cosciens Biopharma Files 6-K for October 2024 — 6-K · Oct 1, 2024
• Cosciens Biopharma Files Routine 6-K Report — 6-K · Sep 23, 2024
• Goodwood Inc. Discloses 10.1% Stake in Cosciens Biopharma — SC 13D · Sep 6, 2024
• Cosciens Biopharma Files 6-K Report — 6-K · Aug 27, 2024
• Cosciens Biopharma Inc. Files Form 6-K — 6-K · Aug 13, 2024
• Aeterna Zentaris Files Form 6-K — 6-K · Aug 7, 2024
• Aeterna Zentaris Files 20-F/A Amendment — 20-F/A · Jul 17, 2024
• Aeterna Zentaris Files June 2024 6-K Report — 6-K · Jun 25, 2024
• Aeterna Zentaris Files Form 6-K — 6-K · Jun 13, 2024
• Aeterna Zentaris Files May 2024 6-K Report — 6-K · Jun 10, 2024
• Aeterna Zentaris INC. SC 13G Filing — SC 13G · Jun 6, 2024
• Aeterna Zentaris Files May 2024 6-K Report — 6-K · May 17, 2024
• Aeterna Zentaris Files May 2024 6-K Report — 6-K · May 16, 2024
• Aeterna Zentaris Files 6-K with Exhibits — 6-K · May 15, 2024
• Aeterna Zentaris Issues Notice of Meeting and Record Date — 6-K · May 14, 2024
• Aeterna Zentaris Completes 1-for-10 Share Consolidation — 6-K · May 9, 2024
• Aeterna Zentaris Announces Reverse Stock Split Effective Date — 6-K · May 1, 2024
• Aeterna Zentaris Announces Final Court Approval for Combination — 6-K · Mar 28, 2024
• Aeterna Zentaris Inc. Files 20-F Annual Report for Fiscal Year Ended December 31, 2023 — 20-F · Mar 27, 2024
• Aeterna Zentaris Shareholders Approve Ceapro Acquisition — 6-K · Mar 13, 2024
• ISS Recommends on Aeterna-Ce Arrangement — 6-K · Feb 27, 2024
• Aeterna Zentaris Files Proxy for Special Shareholder Meeting — 6-K · Feb 20, 2024
• Aeterna Zentaris Inc. Files 20-F/A Amendment — 20-F/A · Feb 15, 2024